Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bethea, Emily D."" wg kryterium: Autor


Tytuł :
Transjugular Intrahepatic Portosystemic Shunt Placement for Portal Hypertension: Meta-Analysis of Safety and Efficacy of 8 mm vs. 10 mm Stents.
Autorzy :
Liu J; Department of Radiology, IR Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.; Department of Gastroenterology, Chinese PLA General Hospital Hainan Hospital, Sanya, Hainan 572016, China.
Wehrenberg-Klee EP; Department of Radiology, IR Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Bethea ED; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Uppot RN; Department of Radiology, IR Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Yamada K; Department of Radiology, IR Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Ganguli S; Department of Radiology, IR Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.; Department of Radiology, Division of Interventional Radiology, Boston Medical Center, Boston University School of Medicine, USA.
Pokaż więcej
Źródło :
Gastroenterology research and practice [Gastroenterol Res Pract] 2020 Oct 17; Vol. 2020, pp. 9149065. Date of Electronic Publication: 2020 Oct 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.
Autorzy :
Julien J; Department of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA.
Ayer T; Department of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Bethea ED; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA.
Tapper EB; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
Chhatwal J; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Public health [Lancet Public Health] 2020 Jun; Vol. 5 (6), pp. e316-e323.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Liver Diseases, Alcoholic/*epidemiology
Liver Diseases, Alcoholic/*mortality
Humans ; Models, Statistical ; Prevalence ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.
Autorzy :
Bloom PP; Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit St, Blake 4, Boston, MA, USA. .; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. .; Department of Medicine, Harvard Medical School, Boston, MA, USA. .
Mojtahed A; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Bethea ED; Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit St, Blake 4, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Knooihuizen SA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Choi J; Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit St, Blake 4, Boston, MA, USA.
Dienstag JL; Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit St, Blake 4, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Chung RT; Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit St, Blake 4, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Hur C; Department of Medicine, Columbia University Irving Medical Center and Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2020 Jan; Vol. 65 (1), pp. 312-321. Date of Electronic Publication: 2019 Jul 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Tomography, X-Ray Computed*
Hepatitis, Alcoholic/*diagnostic imaging
Adult ; Female ; Hepatitis, Alcoholic/complications ; Hepatitis, Alcoholic/mortality ; Hepatitis, Alcoholic/therapy ; Humans ; Male ; Middle Aged ; Patient Admission ; Predictive Value of Tests ; Prognosis ; Registries ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Time Factors
Czasopismo naukowe
Tytuł :
Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.
Autorzy :
Bloom, Patricia P.
Mojtahed, Amirkasra
Bethea, Emily D.
Knooihuizen, Sally A.
Choi, Jin
Dienstag, Jules L.
Chung, Raymond T.
Hur, Chin
Pokaż więcej
Temat :
COMPUTED tomography
HEPATITIS
UNIVARIATE analysis
MULTIVARIATE analysis
PARACENTESIS
RADIOLOGISTS
Źródło :
Digestive Diseases & Sciences; Jan2020, Vol. 65 Issue 1, p312-321, 10p
Czasopismo naukowe
Tytuł :
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
Autorzy :
Bethea ED; Harvard Medical School, Boston, MA, USA; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA.
Gaj K; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Gustafson JL; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA.
Axtell A; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiothoracic Surgery Division, Massachusetts General Hospital, Boston, MA, USA.
Lebeis T; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Schoenike M; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Turvey K; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Coglianese E; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Thomas S; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Newton-Cheh C; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Ibrahim N; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Carlson W; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Ho JE; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Shah R; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Nayor M; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Gift T; Division of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
Shao S; Division of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
Dugal A; Division of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
Markmann J; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, USA.
Elias N; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, USA.
Yeh H; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, USA.
Andersson K; Harvard Medical School, Boston, MA, USA; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA.
Pratt D; Harvard Medical School, Boston, MA, USA; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA.
Bhan I; Harvard Medical School, Boston, MA, USA; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA.
Safa K; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Nephrology Division, Massachusetts General Hospital, Boston, MA, USA.
Fishman J; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Infectious Diseases Division, Massachusetts General Hospital, Boston, MA, USA.
Kotton C; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Infectious Diseases Division, Massachusetts General Hospital, Boston, MA, USA.
Myoung P; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA.
Villavicencio MA; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiothoracic Surgery Division, Massachusetts General Hospital, Boston, MA, USA; Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, USA.
D'Alessandro D; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiothoracic Surgery Division, Massachusetts General Hospital, Boston, MA, USA; Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, USA.
Chung RT; Harvard Medical School, Boston, MA, USA; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA. Electronic address: .
Lewis GD; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA, USA; Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2019 Oct; Vol. 4 (10), pp. 771-780. Date of Electronic Publication: 2019 Jul 26.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Transplantation*
Tissue Donors*
Antiviral Agents/*therapeutic use
Heart/*virology
Hepatitis C, Chronic/*prevention & control
Adult ; Aged ; Benzimidazoles/therapeutic use ; Drug Combinations ; Female ; Follow-Up Studies ; Hemodynamics ; Hepacivirus/isolation & purification ; Hepatitis C, Chronic/transmission ; Humans ; Male ; Middle Aged ; Proof of Concept Study ; Pyrrolidines/therapeutic use ; Quinoxalines/therapeutic use ; Sulfonamides/therapeutic use ; Waiting Lists ; Young Adult
Czasopismo naukowe
Tytuł :
Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.
Autorzy :
Lee BP; Department of Gastroenterology, University of California, San Francisco, San Francisco, California.
Samur S; Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts; Institute for Clinical and Economic Review, Boston, Massachusetts.
Dalgic OO; Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts.
Bethea ED; Massachusetts General Hospital Institute for Technology Assessment, Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Lucey MR; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Weinberg E; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Hsu C; Department of Gastroenterology, Georgetown University School of Medicine, Washington, DC.
Rinella ME; Department of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Im GY; Department of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York City, New York.
Fix OK; Department of Gastroenterology, Swedish Medical Center, Seattle, Washington.
Therapondos G; Department of Gastroenterology, Ochsner Medical Center, Jefferson, Louisiana.
Han H; Department of Gastroenterology, Keck School of Medicine of University of Southern California, Los Angeles, California.
Victor DW; Department of Gastroenterology, Houston Methodist Hospital, Houston, Texas.
Voigt MD; Department of Gastroenterology, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Eswaran S; Department of Gastroenterology, Rush Medical College, Chicago, Illinois.
Terrault NA; Department of Gastroenterology, University of California, San Francisco, San Francisco, California. Electronic address: .
Chhatwal J; Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2019 Aug; Vol. 157 (2), pp. 472-480.e5. Date of Electronic Publication: 2019 Apr 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Models, Biological*
Time-to-Treatment*
End Stage Liver Disease/*surgery
Hepatitis, Alcoholic/*surgery
Liver Transplantation/*methods
Adult ; Alcohol Abstinence ; Alcohol Drinking/adverse effects ; Alcohol Drinking/prevention & control ; End Stage Liver Disease/diagnosis ; End Stage Liver Disease/etiology ; End Stage Liver Disease/mortality ; Female ; Hepatitis, Alcoholic/complications ; Hepatitis, Alcoholic/diagnosis ; Hepatitis, Alcoholic/mortality ; Humans ; Life Expectancy ; Liver Transplantation/standards ; Male ; Middle Aged ; Prospective Studies ; Risk Assessment/methods ; Severity of Illness Index ; Survival Analysis ; Time Factors ; Treatment Outcome ; Waiting Lists
Czasopismo naukowe
Tytuł :
The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.
Autorzy :
Chhatwal J; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Chen Q; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Pennysylvania State University, University Park, Pennsylvania.
Bethea ED; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Hur C; Columbia University Medical Center, New York City, New York.
Spaulding AC; Rollins School of Public Health, Emory University, Atlanta, Georgia.
Kanwal F; Michael E. DeBakey Veterans Affairs Medical Center, and Baylor College of Medicine, Houston, Texas.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Jul; Vol. 50 (1), pp. 66-74. Date of Electronic Publication: 2019 May 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepatitis C/*drug therapy
Hepatitis C/diagnosis ; Hepatitis C/epidemiology ; Humans ; Incidence ; Medicaid ; Medicare ; Models, Theoretical ; United States/epidemiology ; Viremia/drug therapy
Czasopismo naukowe
Tytuł :
Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.
Autorzy :
Bethea ED; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts.
Samur S; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Kanwal F; Department of Medicine, Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas; Houston Veterans Affairs Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
Ayer T; Department of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia.
Hur C; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts.
Roberts MS; Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Terrault N; University of California San Francisco Medical Center, Gastroenterology and Hepatology Division, San Francisco, California.
Chung RT; Harvard Medical School, Boston, Massachusetts; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts.
Chhatwal J; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2019 Mar; Vol. 17 (4), pp. 739-747.e8. Date of Electronic Publication: 2018 Aug 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Cost-Benefit Analysis*
Antiviral Agents/*administration & dosage
Chemoprevention/*methods
Hepatitis C/*drug therapy
Hepatitis C/*transmission
Liver Transplantation/*methods
Adult ; Aged ; Aged, 80 and over ; Female ; Health Care Costs ; Humans ; Male ; Middle Aged ; Models, Theoretical ; Treatment Outcome ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs.
Autorzy :
Chhatwal J; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA. Electronic address: .
Chen Q; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA; Harold and Inge Marcus Department of Industrial and Manufacturing Engineering, Penn State University, State College, PA, USA.
Bethea ED; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA.
Ladd MA; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA.
Mueller PP; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA.
Hutin Y; Global Hepatitis Programme, WHO, Geneva, Switzerland.
Aggarwal R; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2018 Dec; Vol. 3 (12), pp. 819.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Online Systems*
Antiviral Agents/*economics
Antiviral Agents/*therapeutic use
Cost-Benefit Analysis/*methods
Hepatitis C, Chronic/*drug therapy
Health Policy ; Hepatitis C, Chronic/prevention & control ; Humans ; World Health Organization
Raport
Tytuł :
Reply.
Autorzy :
Chhatwal J; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Bethea ED; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Samur S; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Chung RT; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2018 Aug; Vol. 68 (2), pp. 793.
Typ publikacji :
Letter; Comment
MeSH Terms :
Hepacivirus*
Liver Transplantation*
Tissue Donors
Opinia redakcyjna
Tytuł :
Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.
Autorzy :
Chhatwal J; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Samur S; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.
Bethea ED; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Ayer T; Department of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA.
Kanwal F; Department of Medicine, Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX.; Houston Veterans Affairs Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX.
Hur C; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Roberts MS; Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA.; University of Pittsburgh School of Medicine, Pittsburgh, PA.
Terrault N; University of California San Francisco Medical Center, San Francisco, CA.
Chung RT; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2018 Jun; Vol. 67 (6), pp. 2085-2095. Date of Electronic Publication: 2018 Apr 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Liver Transplantation*
Models, Theoretical*
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*prevention & control
Postoperative Complications/*prevention & control
Postoperative Complications/*virology
Hepatitis C, Chronic/complications ; Humans ; Tissue Donors ; Viremia/complications
Czasopismo naukowe
Tytuł :
Reply.
Autorzy :
Bethea ED; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Chen Q; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.
Hur C; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Chung RT; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Chhatwal J; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2018 Apr; Vol. 67 (4), pp. 1641-1642. Date of Electronic Publication: 2018 Feb 27.
Typ publikacji :
Letter; Comment
Opinia redakcyjna
Tytuł :
Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.
Autorzy :
Bethea ED; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Chen Q; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.
Hur C; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Chung RT; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Chhatwal J; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA.; Harvard Medical School, Boston, MA.; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, MA.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2018 Mar; Vol. 67 (3), pp. 837-846. Date of Electronic Publication: 2018 Jan 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Antiviral Agents/*economics
Health Care Costs/*statistics & numerical data
Hepatitis C/*drug therapy
Acute Disease/economics ; Adult ; Antiviral Agents/therapeutic use ; Chronic Disease/economics ; Cost-Benefit Analysis ; Decision Making ; Female ; Hepatitis C/economics ; Humans ; Male ; Models, Theoretical ; Quality of Life ; Quality-Adjusted Life Years ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Reply.
Autorzy :
Samur S; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Bethea ED; Institute for Technology Assessment, Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Chung RT; Harvard Medical School, Boston, Massachusetts; Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts.
Chhatwal J; Institute for Technology Assessment, Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2017 Dec; Vol. 15 (12), pp. 1981. Date of Electronic Publication: 2017 Aug 31.
Typ publikacji :
Letter; Comment
MeSH Terms :
Antiviral Agents*
Coinfection*
Liver Transplantation*
Cost-Benefit Analysis ; HIV ; Hepacivirus ; Hospital Costs ; Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies